Close this search box.

Side effects – a thing of the past….?

European Biotechnology Magazine

Summer Edition, Drug Safety, Vol. 18, 2019


Side effects – a thing of the past….? Despite large investments into drug safety, the pharma industry still loose hundreds of billions by safety-related attrition. Our Senior Vice President Drug Discovery Dr. Torsten Hoffmann was recently interviewed by the European Biotechnology Magazine.

Want to know more about this publication?
Contact our scientists

Medicinal chemistry

Drug Discovery

Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…

custom chemical services

Custom Synthesis

We support our customers by providing first kg quantities of fine and specialty chemicals, cost reduction of existing syntheses, streamlining chemical processes considering…

Looks interesting?

As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
Scroll to Top